ĐẶC ĐIỂM LÂM SÀNG VÀ CHỨC NĂNG THÔNG KHÍ CỦA BỆNH NHÂN SAU MẮC COVID-19

Abstract

Objective: Clinical characteristics and investigation of pulmonary function of patients after COVID-19 at Thai Nguyen university of Medicine and Pharmacy hospital. Methods: Cross-sectional description of clinical characteristics and investigation of pulmonary function of 49 patients after COVID-19 at Thai Nguyen university of Medicine and Pharmacy hospital from 3-12/2022. Results: 55,1% female, 44,9% male. Pulmonary dysfunction: 26,5% female, 20.4% male, 28,6% over 35-year-old patients, 15-35 years old is 18,4%. Most patients have a normal BMI. The time to be positive for COVID-19 less than 1 week is 71,4%, from 1 week or more is 28,6%. The time to come to the doctor after contracting COVID-19 for less than 1 month is 20,4%, from 1 month or more is 79,6%. 83,7% patient had no history of respiratory or diseases affecting the respiratory. The duration of COVID-19 infection after vaccination with the third dose is 180 ± 15 days. Patients have signs of cough is 51%, chest pain is 30,6%, shortness of breath is 44.9%. Patients had Pulmonary dysfunction with cough is 28,6%, with chest pain is 18,4%, with shortness of breath is 18.4%. Mild obstructive ventilation dysfunction was 57,14%, mild restrictive ventilation dysfunction was 14,3%, moderate restrictive ventilation dysfunction was 2,04%. FEF 25-75% has a negative correlation with signs of shortness of breath (p<0.05). Conclusion: Patients with COVID-19 should be investigation of pulmonary function, the suggested FEF index is consistent with clinical symptoms.